Incannex Healthcare Limited Sponsored ADR share price logo

Incannex Healthcare Limited Sponsored ADR

NASDAQ: IXHL

$3.31

+0.16

(+5.08%)

as on

Incannex Healthcare Limited Sponsored ADR Stock Performance

as on September 30, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $3.16
    $3.35
    downward going graph

    4.53%

    Downside

    1.21%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.49
    $15.49
    downward going graph

    24.77%

    Downside

    368.04%

    Upside

    downward going graph

Incannex Healthcare Limited Sponsored ADR share price movements today

Previous Close
$3.15
Open
$3.20
Volume
234.3K
Market Cap
$39.5M
Day's Low - High
$3.16 - $3.35
52 Week Low - High
$2.49 - $15.49

Incannex Healthcare Limited Sponsored ADR Historical Returns

1 Month Return
-9.07 %
3 Month Return
-11.97 %
1 Year Return
-76.24 %
3 Year Return
-90.29 %
5 Year Return
0 %

Incannex Healthcare Limited Sponsored ADR Stock Fundamentals & Key Indicators

Check Incannex Healthcare Limited Sponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$39.5M

EPS (TTM)

-1.29

Dividend Yield

0.00%

PE Ratio (TTM)

-2.44

Industry PE ratio

-7.57

PEG Ratio

-0.06

Return On Equity TTM

-59.80%

Incannex Healthcare Limited Sponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Incannex Healthcare Limited Sponsored ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Incannex Healthcare Limited Sponsored ADR image
Incannex Healthcare Limited Sponsored ADR
NA$39.5MNA-2.44-192.70%0.00%
United Therapeutics image
United Therapeutics
Buy$20.4B153.36%15.7386.14%0.00%
Viatris image
Viatris
Buy$20.5B33.73%-50.7534.83%2.63%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
Buy$39.9BNA18.7565.57%1.35%
Zoetis image
Zoetis
Buy$29.4B-63.79%11.7570.87%2.93%
See all

Stock Returns calculator for Incannex Healthcare Limited Sponsored ADR Stock including INR - Dollar returns

The Incannex Healthcare Limited Sponsored ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Incannex Healthcare Limited Sponsored ADR investment value today

Current value as on today

₹25,633

Returns

-₹74,367

(-74.37%)

Returns from Incannex Healthcare Limited Sponsored ADR Stock

-₹76,237 (-76.24%)

Dollar Impact

₹1,869 (+1.87%)

Indian Investors' Interest in Incannex Healthcare Limited Sponsored ADR Stock

Search interest for Incannex Healthcare Limited Sponsored ADR Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-6% versus previous 30 day period

Incannex Healthcare Limited Sponsored ADR Quarterly Profit & Loss

All numbers in Millions USD

Jun 2021
Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Sep 2024
Jun 2025
Dec 2025
Total Revenue
0
-
0
-
-
-
-
0
-
Gross Profit
0
0
0
-
0
-
-
-
-
Operating Income
-3
-1
-7
-20
-11
-7
-11
-18
-6
EBITDA
-5
-
-10
-2
-9
-1
-9
-39
-6
Interest Expense
-
-
-
-
-
-
-
0
-
Depreciation
3
1
3
0
0
0
0
0
0
Income Before Tax
-3
-1
-4
-20
-11
-1
-9
-44
-6
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-3
-1
-4
-20
71
-1
-9
-35
-6
Net Profit Margin
48.08%
0.00%
78.53%
0.00%
0.00%
0.00%
100.00%
-192.70%
0.00%

Incannex Healthcare Limited Sponsored ADR Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Sep 2024
Jun 2025
Jun 2026
Total Revenue
0
1
1
0
1
0
-
0
0
-
Gross Profit
0
0
0
0
0
0
-
0
0
0
Operating Income
-21
-3
-2
-4
-11
-11
-20
-30
-23
-23
EBITDA
-20
-3
-2
-4
-11
-16
-20
-27
-23
-22
Interest Expense
0
0
0
-
-
-
-
-
0
-
Depreciation
0
0
0
0
7
11
0
0
0
0
Income Before Tax
-21
-
-2
-3
-11
-14
-73
-18
-48
-23
Income Tax Expense
0
0
0
-
-
-
-
0
-1
-4
Net Income
-20
-2
-2
-4
-11
-14
-73
-18
-46
-19
Net Profit Margin
-83.13%
48.23%
50.60%
25.55%
51.94%
0.00%
0.00%
100.00%
-186.05%
0.00%

Incannex Healthcare Limited Sponsored ADR Quarterly Cash Flow

All numbers in Millions USD

Jun 2021
Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Sep 2024
Dec 2024
Jun 2025
Dec 2025
Net Income
-3
-2
-4
-4
-6
-5
-6
-3
-35
-6
Operating Cash Flow
-4
-2
-7
-7
-8
-2
-3
-3
-1
-9
Investing Cash Flow
0
-
-
0
0
0
0
-
0
0
Financing Cash Flow
2
16
12
11
0
-
-
7
17
67
Change in Cash
-3
19
-19
41
-8
-1
-3
4
12
58

Incannex Healthcare Limited Sponsored ADR Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Sep 2024
Jun 2025
Jun 2026
Net Income
-20
-2
-2
-4
-11
-14
-73
-18
-46
-19
Operating Cash Flow
-2
-2
-2
-3
-6
-12
-16
-15
-12
-12
Investing Cash Flow
3
0
0
0
0
-
0
0
0
0
Financing Cash Flow
0
2
2
7
12
41
12
-
21
65
Change in Cash
0
0
0
3
5
28
-5
-16
9
52

Global Institutional Holdings in Incannex Healthcare Limited Sponsored ADR

Check out the Institutions with significant holdings in Incannex Healthcare Limited Sponsored ADR.

Funds
Holdings
Global X
23.13%
AdvisorShares
1.41%
Fidelity Concord Street Trust
0.05%
Victory Portfolios III
0.01%

Incannex Healthcare Limited Sponsored ADR News & Key Events

  • img

    Today's Timeline - 09 September

    Wed, 05:30 PM

    -

    Incannex begins dosing first patient in DReAMzz Phase 2 study for obstructive sleep apnea, supported by positive prior data.

Insights on Incannex Healthcare Limited Sponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 19.38K → 66.61K (in $), with an average increase of 70.9% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -6.52M → -3.88M (in $), with an average increase of 67.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 83.0% return, outperforming this stock by 159.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 83.8% return, outperforming this stock by 174.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, IXHL stock has moved down by -76.2%

About Incannex Healthcare Limited Sponsored ADR

Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid compounds under its proprietary Incannex brand. Its product pipeline includes several key assets: IHL-42X: This compound is currently undergoing Phase II clinical evaluation for the treatment of obstructive sleep apnea (OSA). Incannex partners with The Alfred Hospital and Novotech on this specific clinical program. IHL-216A: Designed to address traumatic brain injury (TBI). Furthermore, the Monash Trauma Group, part of Monash University's Department of Neuroscience, is conducting a study on IHL-216A's protective effects against sports-related concussions. IHL-675A: A unique formulation combining hydroxychloroquine and cannabidiol, developed for both the prevention and management of a range of inflammatory conditions. These include acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, bronchitis, rheumatoid arthritis, and inflammatory bowel diseases. Originally established in 2001 as Impression Healthcare Limited, the company officially changed its name to Incannex Healthcare Limited in June 2020. Incannex maintains its corporate headquarters in Sydney, Australia.
OrganisationIncannex Healthcare Limited Sponsored ADR
Headquarters207/11 Solent Circuit, Sydney, NSW, 2153, AU
IndustryBiotechnology
CEOJoel Bradley Latham

Key Management of Incannex Healthcare Limited Sponsored ADR

Name

Title

Mr. John Michailidis B.Sc., EMBA, M.A.I.C.D.

Chief Executive Officer of IncannexTM

Natalie May

Head of Clinical Operations

Mr. Joel Bradley Latham

President, CEO & Executive Director

Mr. Joseph Swan

CFO, Treasurer & Secretary

Dr. Luigi M. Barbato M.D.

Chief Medical Officer

Mr. Lekhram Changoer M.Sc.

CTO & Member of Advisory Board

Dr. Mark Bleackley Ph.D.

Chief Scientific Officer, Head of Programs & Member of the Advisory Board

FAQs

What is Incannex Healthcare Limited Sponsored ADR share price today?

Incannex Healthcare Limited Sponsored ADR share price today is $3.31 as on at the close of the market. Incannex Healthcare Limited Sponsored ADR share today touched a day high of $3.35 and a low of $3.16.

What is the 52 week high and 52 week low for Incannex Healthcare Limited Sponsored ADR share?

Incannex Healthcare Limited Sponsored ADR share touched a 52 week high of $15.49 on and a 52 week low of $2.49 on . Incannex Healthcare Limited Sponsored ADR stock price today i.e. is closed at $3.31,which is 78.63% down from its 52 week high and 32.93% up from its 52 week low.

What is Incannex Healthcare Limited Sponsored ADR's market capitalisation today?

Incannex Healthcare Limited Sponsored ADR market capitalisation is $0.00T as on .

How to invest in Incannex Healthcare Limited Sponsored ADR Stock (IXHL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Incannex Healthcare Limited Sponsored ADR on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Incannex Healthcare Limited Sponsored ADR Stock (IXHL) from India?

Indian investors can start investing in Incannex Healthcare Limited Sponsored ADR (IXHL) shares with as little as ₹95.83000183105469 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.30 in Incannex Healthcare Limited Sponsored ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Incannex Healthcare Limited Sponsored ADR share’s latest price of $3.31 as on September 30, 2026 at 8:46 am IST, you will get 3.0211 shares of Incannex Healthcare Limited Sponsored ADR. Learn more about fractional shares .